2nd Quarter - Report

FOLEY HOAG LLP for SPECTRUM PHARMACEUTICALS

Firm
Client
Income
$15,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA authority for notification of drug shortages; S. 296 Preserving Access to Life-Saving Medications Act

LobbyistCovered position, as disclosed
BRIAN CAREY —
PAUL KIM —
STACEY SACHS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 296 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.